Summary
The Österreichische Gesundheitskasse (ÖGK) (Austrian health insurance), amended and simplified the regulations for Rx/reimbursement adult incontinence products in 2021. The new rules restrict the number of products to two per day. The health insurance company states that two products per day are sufficient, as incontinence products are increasingly efficient and absorb fluid more effectively.
Rx/Reimbursement adult incontinence in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
